Samuel Sánchez receives the BASF-ICIQ Award for his spin-off Nanobots Therapeutics

The BASFICIQ awards rewards excellence in three key categories: best doctoral thesis, patent and entrepreneurship project, highlighting the transformative potential of researchers and entrepreneurs in the field of chemistry. The company Nanobonts Therapeutics led by IBEC’s Prof. Samuel Sánchez has won the award for its potential to transform treatments for a broad spectrum of medically necessary diseases. The company proposes to develop a technology based on nanorobots with unique tumor penetration capabilities.

You can read the news at Química y sociedad, press and online.